Page 23 - Technology Development Group News Today

One of Apples Biggest Secrets behind their evaluation process of small acquisitions is revealed   People who have joined Apple through an acquisition and participated in the acquisition process told CNBC that Apple’s acquisition strategy focuses on getting talented technical staff from smaller companies, often valuing those companies in terms of the number of engineers working there, and quickly and quietly integrating them into teams at Apple.   Apple has used acquihires to speed expansi...

How Apple does M&A: Small and quiet, with no bankers CNBC 3 hrs ago Kif Leswing In February, Apple CEO Tim Cook told shareholders that the company had bought about 100 companies in the past six years, which works out to the iPhone maker buying a company every three to four weeks. Apples strategy is to buy small small companies, often only employing a few people, primarily for their staff, who become employees at Apple. Apple has gone on sprees picking up multiple firms in fiel...

Xencor begins dosing in Phase I trial of autoimmune disease treatment 29 Apr 2021 (Last Updated April 29th, 2021 17:28) Xencor has dosed the first subject in a Phase I clinical study of an engineered Interleukin-2 (IL-2) Fc cytokine, XmAb564, for the treatment of patients with autoimmune diseases.  Share Article The study will assess the safety, tolerability and pharmacokinetics of subcutaneously administered XmAb564 in healthy adult subjects. Cr...

Stem cell therapy can repair brain damage and improve memory function in mice A one-time injection of an experimental stem cell therapy can repair brain damage and improve memory function in mice with conditions that replicate human strokes and dementia, a new UCLA study finds. Dementia can arise from multiple conditions, and it is characterized by an array of symptoms including problems with memory, attention, communication and physical coordination. The two most common causes of dementia are ...

UCLA Broad Stem Cell Research Center/Science Translational Medicine Microscope images showing brain tissue that has been damaged by white matter stroke (left) and then repaired by the new glial cell therapy (right). Tiare Dunlap | April 21, 2021 A one-time injection of an experimental stem cell therapy can repair brain damage and improve memory function in mice with conditions that replicate human strokes and dementia, a new UCLA study finds. Dementia can arise from multiple conditio...

Share this article Share this article REDWOOD CITY, Calif., April 19, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Jon Shear to the newly created position of Vice President, Corporate Development, effective immediately.   "Jon is uniquely qualified for this new role and brings extensive insight and understanding of the medical technol...

To develop drugs that could help people recover after a stroke

UCLA March 4, 2021 Seventeen researchers at UCLA have been named recipients of awards from the 2020 UCLA Innovation Fund Biomedical Competition. These awards, up to $200,000 per project, support early stage research that lead to commercialization activities, which usually aren’t supported by basic research grants. As a result, researchers can develop their technologies to a point where the chances of success are greatly increased. Importantly, all awarded projects receive consultations from a...

UCLA MedTech/Courtesy of vfairs.com March 3, 2021 WHAT The UCLA Technology Development Group is hosting the ninth annual MedTech Partnering Conference. The event is dedicated to providing unique opportunities for inventors, researchers, scientists and medical and technology industry executives to establish relationships that will help further innovations in the fields of medicine, research and technology.  The 2021 gathering will be the first-ever virtual conference in the event’s history. T...

UCLA Health Dr. Rhonda Voskuhl Through a new collaboration with a South Korean pharmaceutical company, UCLA scientists will participate in the...